INTERNATIONAL PATENT: GENENTECH, INC., F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC., FLINN, IAN, W., BURKE, JOHN, M. FILES APPLICATION FOR "METHODS OF TREATING CANCER USING SUBCUTANEOUS DOSING OF MOSUNETUZUMAB AS A MONOTHERAPY OR IN COMBINATION WITH LENALIDOMIDE"

GENEVA, Jan. 6 -- GENENTECH, INC. (1 Dna WaySouth San Francisco, CA 94080-4990), F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (150 Clove Road, Overlook At Great Notch, Suite 8Little Falls, NJ 07424), FLINN, Ian, W. (9541 Sanctuary PlaceBrentwood, TN 37027), BURKE, John, M. (1700 S. Potomac St.Aurora, CO 80012) filed a patent application (PCT/US2025/035264) for "METHODS OF TREATING CANCER USING SUBCUTANEOUS DOSING OF MOSUNETUZUMAB AS A MONOTHERAPY OR IN COMBINATION WITH LENALIDOMIDE" on Jun 25, 2025. With publication no. WO/2026/006456, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (...